News

The Hidradenitis Suppurativa Foundation offers grants for HS research and clinical expertise, supporting early-stage to established investigators.

Block emphasized the importance of breakout sessions geared toward varying levels of experience—beginner, intermediate, and advanced.

Delgocitinib is indicated for adults with CHE who either do not respond to or cannot use topical corticosteroids.

The conference aimed at providing physician assistants with the latest in dermatology advancements begins today in Las Vegas, Nevada.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

The study calls for improved diversity in clinical training materials to help future clinicians better recognize conditions on darker skin.

Join Dermatology Times in celebrating National Healthy Skin Month.

A study showed NB-UVB phototherapy effectively reduced prurigo nodularis symptoms, with 80% of patients achieving full response.

A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.

RAD will join MJH's multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.

Abeona's pz-cel has been granted a April 29, 2025, PDUFA date.

Murase discussed safe dermatologic treatments during lactation, especially for chronic conditions needing biologics.

Jamie Restivo, MPAS, PA-C, shares some insights from the 5th Annual Keystone Dermatology Conference held from October 17 to 19 in Philadelphia, Pennsylvania.

When it comes to improving health outcomes, representation matters! Learn how Johnson & Johnson is collaborating with leaders in the field of dermatology and striving to support diverse talent in dermatology practice and research to advance innovative solutions for patients.

Murase identifies 4 main pregnancy dermatoses—atopic eruption, polymorphic eruption, extrahepatic cholestasis, and pemphigoid gestationis—as "baby bumps."

With the Affordable Care Act's uncertain future, many Americans are curious about Robert F. Kennedy Jr.'s potential role in the new administration.

David M. Pariser, MD, FACP, FAAD, secretary and a founding board member of the International Hyperhidrosis Society, discussed the latest in hyperhidrosis research and the organization’s commitment to helping clinicians treat the condition.

Catch up on coverage from the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Catch up on coverage from the fourth and final day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Discover top innovations, insights, and clinical pearls from Elevate-Derm in Scottsdale, where top insights for advanced practice providers took center stage.

At Elevate-Derm West, Murase shared promising results in treating severe itch with emerging therapies, offering hope for patients with few options.

Swanson shared practical tips from her Elevate-Derm West sessions, empowering clinicians with new strategies for pediatric skin care.

Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.

Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.

Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

The study demonstrated significant reductions in inflammatory and non-inflammatory lesions for Hispanic patients using CAB gel.

Chilukuri shared that 2 new sunscreen ingredients, physalis angulata and pycnogenol, can prevent heat-induced pigmentation, offering new options for patients.

Delgocitinib cream offers a safe, low-systemic-exposure option for chronic hand eczema, according to a poster from the Elevate-Derm conference.

Affordable at-home treatments, including microneedling and benzoyl peroxide, were top pearls at Chilukuri's Elevate-Derm session.

The TRACE study showed tralokinumab reduced genital AD severity and improved quality of life within 3 months of treatment.